PFE241220P30000
- 4.40
- -0.27-5.78%
Pfizer Newsroom
Wells Fargo Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $27
Pfizer (PFE) Gets a Hold From Wells Fargo
Goldman Sachs Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $33
Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $33
Jefferies Sticks to Their Buy Rating for Pfizer (PFE)
Wells Fargo Adjusts Price Target on Pfizer to $27 From $30
A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $28 to $33
Pfizer (PFE) Gets a Hold From J.P. Morgan
Cautious Outlook: Pfizer's EPS Downgrade and Conservative Guidance Prompt Hold Rating
Pfizer Analyst Ratings
Pfizer (PFE) Gets a Buy From Evercore ISI
Guggenheim Adjusts Price Target on Pfizer to $33 From $35, Keeps Buy Rating
Pfizer Analyst Ratings
B of A Securities Reinstates Neutral on Pfizer, Announces $29 Price Target
Berenberg Bank Maintains Pfizer(PFE.US) With Hold Rating, Raises Target Price to $29
Berenberg Bank Sticks to Their Hold Rating for Pfizer (PFE)
Morgan Stanley Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $31
Leerink Partners Maintains Pfizer(PFE.US) With Hold Rating
BioNTech Stock Has Been Hit Hard Since RFK Jr.'s Nomination. Why This Analyst Upgraded It. -- Barrons.com
Wolfe Research Initiates Pfizer at Underperform With $25 Price Target